Roche Venture Fund

Roche Venture Fund

Roche Venture Fund is a corporate venture fund of Roche founded in 2002.

Roche Venture Fund is a Basel, Switzerland based venture capital fund of Roche Holding founded in 2002.

The firm seeks to invest in life science companies in the pharmaceuticals and diagnostics sectors. The firm invests in early-stage and growth stages.

The notable investment portfolio of Roche Venture Fund includes Arch Oncology, Entrada Therapeutics, Freenome, Good Therapeutics, Jasper Therapeutics, MacuLogix, Minoryx Therapeutics, Biodesy, Purigen Biosystems, and Second Genome, etc.

As of January 2020, Roche Venture Fund has made 129 investments and had 67 exits.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
CytomX Therapeutics

A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.

Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions and technologies for cancer care founded in 2010 by Alexis Borisy.

An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.

A company that offers gene editing, CRO and diagnostics services

A diagnostics company providing real-time biopsy material to guide personalized medicine for cancer patients

Maculogix is a Harrisburg, Pennsylvania-based diagnostics company focused on detection and tracking age-related macular degeneration.

Viracor-IBT Laboratories is a Lee's Summit, Missouri-based diagnostics laboratory specialized in allergy, immunology, and infectious disease testing.

MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes.

Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.

Conatus Pharmaceuticals is a San Diego-based company.

A biopharmaceutical company developing stapled peptide therapeutics for the treatment of cancers and other diseases

A protein analysis company developing products and systems to analyze protein

IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality

A biotechnology company developing medicines to treatment viral diseases

A company developing biologically active compounds and drug candidates

A company that develops therapeutic antibodies to treat diseases and allergies

A biotechnology company that develops RNA interference therapeutics

A company developing Innate Defense Regulators

Vivet Therapeutics is a France-based company.

Opsona Therapeutics is a Dublin-based company.

Arch Oncology is a Brisbane, California-based company.

26 Results
Page 1 of 2
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Anja Harmeier

Investment Director

Carole Nuechterlein

Head Roche Venture Fund

David Evans

Investment Director

Gabriella Zöch

Project Associate

Karl Handelsman

Investment Director

Mitchell Mutz

Investment Director

Nisha Marathe

Investment Manager

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Arch Oncology

Biodesy

Entrada Therapeutics

Freenome

Good Therapeutics

Jasper Therapeutics

MacuLogix

Minoryx Therapeutics

Purigen Biosystems

Second Genome

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.